Candriam SCA
CHE icon

Candriam SCA’s Chemed CHE Stock Holding History

Candriam SCA’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-41,398
Closed -$19.3M – 662
2026
Q2 		$19.3M Sell
41,398
-1,844
-4% -$775K 0.09% 205
2026
Q1 		$16.3M Sell
43,242
-12,989
-23% -$5.56M 0.08% 221
2025
Q4 		$24.1M Buy
56,231
+13,175
+31% +$5.74M 0.12% 172
2025
Q3 		$19.3M Sell
43,056
-12,553
-23% -$5.68M 0.1% 185
2025
Q2 		$27.1M Buy
55,609
+10,431
+23% +$5.94M 0.16% 124
2025
Q1 		$27.8M Buy
45,178
+30,495
+208% +$17.3M 0.17% 122
2024
Q4 		$7.78M Sell
14,683
-1,328
-8% -$749K 0.04% 298
2024
Q3 		$9.6M Buy
16,011
+6,290
+65% +$3.57M 0.06% 276
2024
Q2 		$5.27M Buy
+9,721
New +$5.57M 0.03% 336

Other funds holding CHE

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
River Road Asset Management
River Road Asset Management Louisville, Kentucky $8.42B AUM 5.65% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Copeland Capital Management
Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return
Van Berkom & Associates
Van Berkom & Associates Montreal, Quebec, Canada $2.81B AUM 6.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Candriam SCA's CHE Position: Q3 2026 in Review

Candriam SCA sold out of Chemed (CHE) in Q3 2026, closing a stake of 41,398 shares — an estimated $19.3M sold.

Candriam SCA first reported a position in CHE in Q2 2024 and held it in 9 quarters. The position peaked at $27.8M in Q1 2025. 306 funds tracked by Wall St. Rank hold CHE as of Q3 2026.

  • Candriam SCA reported no remaining Chemed position as of Q3 2026 after selling out during the quarter.
  • Candriam SCA sold 41,398 Chemed shares in Q3 2026, an estimated $19.3M.
  • Candriam SCA first reported a position in Chemed in Q2 2024 and held it in 9 quarters.
  • Candriam SCA's Chemed position peaked at $27.8M in Q1 2025.
  • 306 funds tracked by Wall St. Rank held Chemed as of Q3 2026.

Based on Candriam SCA's 13F filing for Q3 2026, filed 3 Nov 2026.